OTCMKTS:ANPCY

ANGLE (ANPCY) Stock Price, News & Analysis

C$1.89
0.00 (0.00%)
(As of 05/1/2024 ET)
Today's Range
C$1.89
C$1.89
50-Day Range
C$1.80
C$1.98
52-Week Range
C$1.13
C$4.00
Volume
N/A
Average Volume
1,105 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ANPCY stock logo

About ANGLE Stock (OTCMKTS:ANPCY)

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.

ANPCY Stock Price History

ANPCY Stock News Headlines

ANGLE unveils groundbreaking cancer diagnostic tool
He Is Giving Away Bitcoin
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
He Is Giving Away Bitcoin
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Angle: Big Takeaways
Angle: An Escape for New York
See More Headlines
Receive ANPCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
OTCMKTS:ANPCY
Fax
N/A
Employees
173
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Andrew David William Newland ACA (Age 63)
    Meng, Founder, CEO & Executive Director
    Comp: $326.51k
  • Mr. Ian Francis Griffiths ACA (Age 60)
    BA, CFO, Finance Director, Company Secretary & Executive Director
    Comp: $202.84k
  • Mr. Martin Cooke (Age 55)
    Director of Operations & Regulatory Affairs
  • Dr. Karen Miller Ph.D.
    Chief Scientific Officer
  • Mr. Andrew John Holder (Age 56)
    Head of Investor Relations
  • Ms. Anne-Sophie Pailhes-Jimenez
    Head of R&D and Senior Director
  • Mr. Brett Swansiger
    Chief Commercial Officer
  • Mr. Nick Claxton
    Senior Vice President of Commercial Operations

ANPCY Stock Analysis - Frequently Asked Questions

How have ANPCY shares performed in 2024?

ANGLE's stock was trading at C$1.52 on January 1st, 2024. Since then, ANPCY stock has increased by 24.3% and is now trading at C$1.89.
View the best growth stocks for 2024 here
.

How do I buy shares of ANGLE?

Shares of ANPCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ANPCY) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners